Back to Journals » Patient Intelligence » Volume 4

Impact of antidepressant treatment: a study from The Netherlands

Authors van Dongen N, Mason

Received 5 May 2012

Accepted for publication 11 June 2012

Published 18 July 2012 Volume 2012:4 Pages 63—70


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Nadine van Dongen,1 Scott Mason2

1PIP Health Ltd, London, United Kingdom; 2London Metropolitan University, London, United Kingdom

Background: The purpose of the study was to identify the extent and severity of treatment-related side effects experienced by patients with depression. The study was designed to identify the extent of the different antidepressant side effects to gain an understanding of their impact on the lives of patients suffering from depression.
Methods: A total of 303 patients from The Netherlands with physician-diagnosed depression completed an online questionnaire. All participating patients were receiving antidepressants and were members of the Patient Intelligence Panel (PIP). Participants answered questions about their antidepressant medication, degree of personal research into antidepressant medication, and about any side effects they had experienced as a result of their current antidepressant therapy, the severity of any such side effects, and the impact on their daily lives.
Results: Over two-thirds (69%) of patients were receiving antidepressant therapy for the first time. Forty-two percent (42%) of patients felt it took 2–6 weeks of antidepressant therapy before their depressive mood improved. More than half of participating patients (60%) had experienced side effects from their antidepressant therapy, the most common being ‘somnolence, drowsiness, or fatigue’ (14%). Of the 60% of patients who had experienced side effects, 46% admitted to absenteeism as a consequence.
Conclusion: Central to the effective management of depression is an understanding of the effects of antidepressant therapy on patients’ lives. Treatment-related side effects, and their potential influence on treatment discontinuation, need to be recognized and assessed on an individual patient basis to optimize management and minimize potential relapse.

Keywords: depression, antidepressants, SSRI, side effects, The Netherlands

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Other articles by this author:

Readers of this article also read:

Empowerment in people with COPD

Disler RT, Appleton J, Smith TA, Hodson M, Inglis SC, Donesky D, Davidson PM

Patient Intelligence 2016, 8:7-20

Published Date: 30 December 2015

Insulin-taking behavior and memory problems among people with diabetes in five countries: findings from a web survey

Brod M, Pfeiffer KM, Mandel Clausen K, Skovgaard R, Kongsø JH

Patient Intelligence 2014, 6:43-60

Published Date: 10 November 2014

Patient knowledge, perceptions, and acceptance of generic medicines: a comprehensive review of the current literature

Alrasheedy AA, Hassali MA, Stewart K, Kong DCM, Aljadhey H, Mohamed Ibrahim MI, Al-Tamimi SK

Patient Intelligence 2014, 6:1-29

Published Date: 3 April 2014

Optimal management of severe nausea and vomiting in migraine: improving patient outcomes

Láinez MJ, García-Casado A, Gascón F

Patient Related Outcome Measures 2013, 4:61-73

Published Date: 11 October 2013

Patient considerations in the management of mental stress in psoriasis

Schmid-Ott G, Böhm D, Stock Gissendanner S

Patient Intelligence 2012, 4:41-50

Published Date: 14 June 2012

Patient and public perspectives shaping scientific and medical research: panels for data, discussions, and decisions

Uhm S, Liabo K, Stewart R, Rees R, Oliver S

Patient Intelligence 2012, 4:1-10

Published Date: 16 January 2012